The Daily Pennsylvanian is a student-run nonprofit.

Please support us by disabling your ad blocker on our site.

ethanyoung-board-of-trustees
Vice Provost and Dean of Admissions Whitney Soule presented admissions statistics for the Class of 2028 at the University Board of Trustees meeting on June 14. Credit: Ethan Young

Vice Provost and Dean of Admissions Whitney Soule announced admissions statistics for the Class of 2028, Penn's most selective admissions cycle on record, at the University Board of Trustees spring full board meeting on June 14.

Out of a pool of 65,235 applicants, 3,508 students were admitted, resulting in an acceptance rate of 5.4%. The Class of 2028 consists of 2,400 students from 47 states and 95 countries. Legacy students constitute 14% of the class, and 14.5% are from Pennsylvania.

The Class of 2028 is also the first class to be admitted to the University following the overturning of affirmative action last June and will arrive on campus following a year marked by increased levels of protest at Penn.

“The higher admissions landscape experienced significant adjustments and complications this year, including the Supreme Court's elimination of considering race in admissions evaluations, exceptionally complicated circumstances related to federal financial aid programs, and the pressure of world events on college campuses, including at Penn,” Soule said at the meeting. “With all this, we were especially impressed with the accomplishment, resolve, and ambition demonstrated by the students who committed to the Class of 2028.”

The spring full board meeting proceeded despite the Board's winter meeting being cut short after a group of 12 pro-Palestinian protesters affiliated with the Freedom School for Palestine entered the space to protest for “endowment transparency.”

On Friday, Ramanan Raghavendran and Julie Platt were re-elected as chair and vice chair of the Board, respectively. The Board also voted to approve the 2025 fiscal year operating budget and to authorize up to $39 million for a 42,000-square-foot cancer center at Penn Presbyterian Medical Center.